Literature DB >> 28239752

Potential and Limitations of Cochrane Reviews in Pediatric Cardiology: A Systematic Analysis.

Martin Poryo1, Sara Khosrawikatoli2, Hashim Abdul-Khaliq3, Sascha Meyer4,5.   

Abstract

Evidence-based medicine has contributed substantially to the quality of medical care in pediatric and adult cardiology. However, our impression from the bedside is that a substantial number of Cochrane reviews generate inconclusive data that are of limited clinical benefit. We performed a systematic synopsis of Cochrane reviews published between 2001 and 2015 in the field of pediatric cardiology. Main outcome parameters were the number and percentage of conclusive, partly conclusive, and inconclusive reviews as well as their recommendations and their development over three a priori defined intervals. In total, 69 reviews were analyzed. Most of them examined preterm and term neonates (36.2%), whereas 33.3% included also non-pediatric patients. Leading topics were pharmacological issues (71.0%) followed by interventional (10.1%) and operative procedures (2.9%). The majority of reviews were inconclusive (42.9%), while 36.2% were conclusive and 21.7% partly conclusive. Although the number of published reviews increased during the three a priori defined time intervals, reviews with "no specific recommendations" remained stable while "recommendations in favor of an intervention" clearly increased. Main reasons for missing recommendations were insufficient data (n = 41) as well as an insufficient number of trials (n = 22) or poor study quality (n = 19). There is still need for high-quality research, which will likely yield a greater number of Cochrane reviews with conclusive results.

Entities:  

Keywords:  Cochrane reviews; Evidence-based medicine; Pediatric cardiology

Mesh:

Year:  2017        PMID: 28239752     DOI: 10.1007/s00246-017-1572-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  75 in total

Review 1.  Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.

Authors:  Reineke A Schoot; Leontien C M Kremer; Marianne D van de Wetering; Cornelia H van Ommen
Journal:  Cochrane Database Syst Rev       Date:  2013-09-11

Review 2.  Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants.

Authors:  Edward F Bell; Michael J Acarregui
Journal:  Cochrane Database Syst Rev       Date:  2014-12-04

Review 3.  Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.

Authors:  Manoj N Malviya; Arne Ohlsson; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

Review 4.  Laryngeal mask airway versus bag-mask ventilation or endotracheal intubation for neonatal resuscitation.

Authors:  A J Grein; G M Weiner
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 5.  Lipid-lowering efficacy of atorvastatin.

Authors:  Stephen P Adams; Michael Tsang; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2015-03-12

Review 6.  Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants.

Authors:  Arne Ohlsson; Prakeshkumar S Shah
Journal:  Cochrane Database Syst Rev       Date:  2015-03-11

Review 7.  Interventions for treating tuberculous pericarditis.

Authors:  B M Mayosi; M Ntsekhe; J A Volmink; P J Commerford
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 8.  Repetitive transcranial magnetic stimulation for improving function after stroke.

Authors:  Zilong Hao; Deren Wang; Yan Zeng; Ming Liu
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

Review 9.  Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.

Authors:  C Herrera; J Holberton; P Davis
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

Review 10.  Indomethacin for asymptomatic patent ductus arteriosus in preterm infants.

Authors:  L Cooke; P Steer; P Woodgate
Journal:  Cochrane Database Syst Rev       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.